Cellules souche et Dérivés
Les inhibiteurs de cellules souches sont des composés qui ciblent spécifiquement les voies de signalisation et les protéines impliquées dans le maintien, la différenciation et la prolifération des cellules souches. Ces inhibiteurs sont cruciaux pour comprendre la biologie des cellules souches et pour développer des stratégies visant à manipuler les cellules souches à des fins thérapeutiques, telles que la médecine régénérative et le traitement du cancer. En contrôlant le destin des cellules souches, ces inhibiteurs peuvent aider à orienter la différenciation des cellules souches en types cellulaires spécifiques ou à prévenir une croissance cellulaire indésirable. Chez CymitQuimica, nous offrons une sélection d'inhibiteurs de cellules souches de haute qualité pour soutenir vos recherches en biologie des cellules souches, biologie du développement et médecine régénérative.
Sous-catégories appartenant à la catégorie "Cellules souche et Dérivés"
- Gamma-sécrétase(61 produits)
- Hérisson/Smoothened(49 produits)
- Voie de signalisation Hippo(7 produits)
- JAK(243 produits)
- Porc-épic(9 produits)
- ROCK(62 produits)
- STAT(98 produits)
- Cellules souches(202 produits)
- TGF-beta/Smad(59 produits)
- Wnt/beta-caténine(59 produits)
Affichez 2 plus de sous-catégories
484 produits trouvés pour "Cellules souche et Dérivés"
Trier par
Degré de pureté (%)
0
100
|
0
|
50
|
90
|
95
|
100
Belumosudil
CAS :Belumosudil (Rezurock) is an orally available, and specific ROCK2 inhibitor (IC50/Ki: 60/41 nM).Formule :C26H24N6O2Degré de pureté :97.64% - 98.59%Couleur et forme :SolidMasse moléculaire :452.51Ref: TM-T6867
2mg48,00€5mg73,00€10mg90,00€25mg166,00€50mg250,00€100mg376,00€500mg895,00€1mL*10mM (DMSO)79,00€BD750
CAS :BD750 is an effective immunosuppressant and a JAK3/STAT5 inhibitor, inhibits IL-2-induced JAK3/STAT5-dependent T cell proliferation(IC50 of 1.5 μM and 1.1 μM inFormule :C14H13N3OSDegré de pureté :99.02%Couleur et forme :SolidMasse moléculaire :271.34Pacritinib hydrochloride
CAS :Pacritinib HCl: strong JAK2/Wild-type & JAK2V617F inhibitor (IC50: 23/19 nM), used in AML & MF research.Formule :C28H32N4O3·xClHCouleur et forme :Solid2,6-Dichloro-N-(2-(cyclopropanecarboxamido)pyridin-4-yl)benzamide
CAS :2,6-Dichloro-N-(2-(cyclopropanecarboxamido)pyridin-4-yl)benzamide (GDC046), a potent lead analog, has good kinase selectivity and physicochemical properties.Formule :C16H13Cl2N3O2Degré de pureté :98.77%Couleur et forme :SolidMasse moléculaire :350.2IHR-1
CAS :IHR-1, a Smo inhibitor (IC50 7.6 nM), blocks Hedgehog pathway, not Wnt/Notch, and prevents Smo in primary cilium.Formule :C20H12Cl4N2O2Degré de pureté :97.02%Couleur et forme :SolidMasse moléculaire :454.13Ref: TM-T24159
2mg33,00€5mg50,00€10mg80,00€25mg131,00€50mg193,00€100mg290,00€200mg416,00€1mL*10mM (DMSO)55,00€MRT-14
CAS :MRT-14 is a potent Smo antagonist and can be used in several types of cancers linked to abnormal Hh signaling studies.Formule :C24H24N4O5Degré de pureté :99.54%Couleur et forme :SolidMasse moléculaire :448.47SAR-20347
CAS :SAR-20347 is an inhibitor of TYK2, JAK1/2/3 (IC50: 0.6/23/26/41 nM).Formule :C21H18ClFN4O4Degré de pureté :98.99% - 99.77%Couleur et forme :SolidMasse moléculaire :444.84Ref: TM-T4210
1mg34,00€5mg75,00€10mg110,00€25mg215,00€50mg334,00€100mg557,00€200mg775,00€1mL*10mM (DMSO)84,00€LY3200882
CAS :LY3200882 is a highly selective inhibitor of TGF-β receptor type 1 (TGFβRI).Formule :C24H29N5O3Degré de pureté :99.46% - 99.63%Couleur et forme :SolidMasse moléculaire :435.52Fosciclopirox
CAS :Fosciclopirox (CPX-POM), the phosphoryloxymethyl ester of CPX (Ciclopirox Prodrug, CPX-POM), selectively delivers the active metabolite, CPX, to the entireFormule :C13H20NO6PDegré de pureté :99.83%Couleur et forme :SolidMasse moléculaire :317.27Ref: TM-T9422
2mg35,00€5mg52,00€10mg90,00€25mg170,00€50mg259,00€100mg383,00€200mg545,00€1mL*10mM (DMSO)58,00€Atractylenolide I
CAS :Atractylenolide-I reduces inflammation, improves sepsis, liver, and kidney function, and enhances EOC cell sensitivity to paclitaxel.Formule :C15H18O2Degré de pureté :97.55% - 99.92%Couleur et forme :SolidMasse moléculaire :230.30AR-A014418
CAS :AR-A014418 (GSK 3β inhibitor VIII) is an ATP-competitive, and selective GSK3β inhibitor.Formule :C12H12N4O4SDegré de pureté :>99.99% - ≥95%Couleur et forme :SolidMasse moléculaire :308.31GLPG0634 analog
CAS :GLPG0634 analog (GLPG0634 analogue) is a specific JAK1 inhibitor with IC50 of 10/28/810/116 nM for JAK1/2/3 and TYK2, respectively.Formule :C23H18N6O2Degré de pureté :99.52% - >99.99%Couleur et forme :SolidMasse moléculaire :410.43Ref: TM-T3076
1mg38,00€2mg50,00€5mg84,00€10mg137,00€25mg250,00€50mg442,00€100mg623,00€500mg1.305,00€1mL*10mM (DMSO)93,00€Lats-IN-1
CAS :Lats-IN-1 is a potent and ATP-competitive Lats1 and Lats2 kinases inhibitor. It promotes Yap-dependent proliferation in postmitotic mammalian tissues.Formule :C18H14N4OSDegré de pureté :97.54% - 99.79%Couleur et forme :SolidMasse moléculaire :334.39Ref: TM-T9053
1mg50,00€2mg70,00€5mg100,00€10mg159,00€25mg294,00€50mg394,00€100mg560,00€200mg798,00€1mL*10mM (DMSO)112,00€IMR-1
CAS :IMR-1 is a novel class of Notch inhibitors targeting the transcriptional activation with IC50 of 6 μMol/L.Formule :C15H15NO5S2Degré de pureté :97.96% - 98.38%Couleur et forme :SolidMasse moléculaire :353.41XL019
CAS :XL019 is a potent and selective JAK2 inhibitor with IC50 of 2.2 nM, 100 fold selectivity over JAK1.Formule :C25H28N6O2Degré de pureté :99.19%Couleur et forme :SolidMasse moléculaire :444.53Ref: TM-T3072
2mg43,00€5mg63,00€10mg92,00€25mg150,00€50mg215,00€100mg321,00€200mg477,00€1mL*10mM (DMSO)78,00€MK-0752 Sodium
CAS :Sodium MK-0752 is a novel and potent gamma-secretase inhibitor that has been evaluated in clinical trials for the treatment of various types of cancer.Formule :C21H21ClF2NaO4SCouleur et forme :SolidMasse moléculaire :465.89ZM39923 hydrochloride
CAS :ZM39923 hydrochloride (JAK3 Inhibitor IV) is an JAK1/3 inhibitor, almost no activity to JAK2 and modestly potent to EGFR; also is sensitive to transglutaminase.Formule :C23H25NO·HClDegré de pureté :98.05%Couleur et forme :SolidMasse moléculaire :367.91SB 216763
CAS :SB 216763 (SB216763) is an effective and specific GSK-3α/β inhibitor (IC50: 34.3 nM).Formule :C19H12Cl2N2O2Degré de pureté :98.9% - 99.13%Couleur et forme :SolidMasse moléculaire :371.22Ref: TM-T3077
2mg39,00€5mg52,00€10mg79,00€25mg131,00€50mg197,00€100mg334,00€500mg803,00€1mL*10mM (DMSO)52,00€JANEX-1
CAS :JANEX-1: cell-permeable, reversible Jak3 inhibitor (IC50: 78 μM), ATP-competitive, selective; weak on JAK1/2, Zap/Syk, SRC.Formule :C16H15N3O3Degré de pureté :98% - 99.81%Couleur et forme :SolidMasse moléculaire :297.31Peficitinib
CAS :Peficitinib (ASP015K) (ASP015K, JNJ-54781532) is an orally bioavailable JAK inhibitor. Phase 3.Formule :C18H22N4O2Degré de pureté :98.67% - 99.4%Couleur et forme :SolidMasse moléculaire :326.39Ref: TM-T6933
2mg38,00€5mg63,00€10mg99,00€25mg172,00€50mg268,00€100mg416,00€200mg610,00€1mL*10mM (DMSO)70,00€LY900009
CAS :LY900009 is a small molecule inhibitor of Notch signalling via selective inhibition of the γ-secretase protein.Formule :C23H27N3O4Degré de pureté :97.07%Couleur et forme :SolidMasse moléculaire :409.48Ref: TM-T9015
1mg35,00€5mg80,00€10mg112,00€25mg197,00€50mg290,00€100mg420,00€200mg590,00€1mL*10mM (DMSO)87,00€Protosappanin A
CAS :Protosappanin A combats brain inflammation, suppresses rat heart transplant rejection, fights MRSA, and inhibits HIV with a 12.6 uM IC50.Formule :C15H12O5Degré de pureté :99.42% - 99.82%Couleur et forme :SolidMasse moléculaire :272.25Ref: TM-TJS1779
1mg88,00€5mg195,00€10mg318,00€25mg523,00€50mg743,00€100mg999,00€1mL*10mM (DMSO)178,00€Delgocitinib EtOH
CAS :Delgocitinib (LEO-124249/JTE052) is a selective JAK inhibitor used for reducing skin inflammation and treating chronic dermatitis.Formule :C18H24N6O2Couleur et forme :SolidMasse moléculaire :356.43Deucravacitinib
CAS :Deucravacitinib (BMS-986165) is a highly selective, orally bioavailable, allosteric TYK2 inhibitor.Cost-effective and quality-assured.Formule :C20H19D3N8O3Degré de pureté :98.52% - >99.99%Couleur et forme :SolidMasse moléculaire :425.46Ref: TM-T14687
1mg56,00€5mg137,00€10mg248,00€25mg389,00€50mg575,00€100mg817,00€1mL*10mM (DMSO)149,00€Momelotinib
CAS :Momelotinib (LM-1149), an oral JAK1/2 inhibitor with IC50s 11/18 nM, blocks ATP binding, disrupting JAK-STAT pathway and reducing tumor growth.Formule :C23H22N6O2Degré de pureté :97.07% - 99.56%Couleur et forme :SolidMasse moléculaire :414.46Ref: TM-T1849
1mg35,00€2mg50,00€5mg77,00€10mg89,00€25mg158,00€50mg245,00€100mg385,00€200mg592,00€1mL*10mM (DMSO)84,00€(Z)-LFM-A13
CAS :(Z)-LFM-A13(IC50=2.5 μM), a specific Bruton's tyrosine kinase (BTK), is more than 100-fold specificity than other protein kinases, such as JAK1, JAK2, HCK, EGFR, and IRK.Formule :C11H8Br2N2O2Degré de pureté :99.88%Couleur et forme :SolidMasse moléculaire :360VP3.15 dihydrobromide
CAS :VP3.15 dihydrobromide: potent, oral, CNS-penetrant PDE7/GSK3 inhibitor; IC50s: PDE7- 1.59 μM, GSK- 0.88 μM.Formule :C20H24Br2N4OSDegré de pureté :99.67% - ≥95%Couleur et forme :SolidMasse moléculaire :528.3LGK974
CAS :LGK974 (NVP-LGK974) is a selective PORCN inhibitor that blocks Wnt signaling, used in metastatic colorectal and head/neck cancer trials. IC50: 0.4 nM.Formule :C23H20N6ODegré de pureté :98.8% - >99.99%Couleur et forme :SolidMasse moléculaire :396.44Ref: TM-T2618
1mg46,00€2mg62,00€5mg90,00€10mg156,00€25mg288,00€50mg515,00€100mg737,00€1mL*10mM (DMSO)90,00€PF-670462
CAS :PF-670462 is a potent (IC50 = 7.7 ± 2.2 nM) and selective (>30-fold with respect to 42 additional kinases) inhibitor of CK1ε in isolated enzyme preparations.Formule :C19H22Cl2FN5Degré de pureté :99.42% - 99.72%Couleur et forme :SolidMasse moléculaire :410.32MYF-01-37
CAS :MYF-01-37 (1-[3-Methyl-3-[3-(trifluoromethyl)anilino]pyrrolidin-1-yl]prop-2-en-1-one) is a novel covalent TEAD inhibitor.Formule :C15H17F3N2ODegré de pureté :99.46% - 99.5%Couleur et forme :SolidMasse moléculaire :298.3Ref: TM-T22372
2mg38,00€5mg57,00€10mg90,00€25mg166,00€50mg281,00€100mg421,00€500mg888,00€1mL*10mM (DMSO)63,00€AT9283
CAS :AT9283 (J-504568) is an effective multi-targeted inhibitor of JAK2(IC50=1.2 nM) and JAK3(IC50=1.1 nM), Aurora A, Aurora B and Abl(T315I).
Formule :C19H23N7O2Degré de pureté :99.83% - 99.98%Couleur et forme :SolidMasse moléculaire :381.43Curculigoside
CAS :1.Formule :C22H26O11Degré de pureté :99.85%Couleur et forme :SolidMasse moléculaire :466.44CEP-33779
CAS :CEP-33779 is a novel and selective inhibitor of JAK2 with an IC50 of 1.8±0.6 nM.Formule :C24H26N6O2SDegré de pureté :98.24% - ≥95%Couleur et forme :SolidMasse moléculaire :462.57Ref: TM-T6122
1mg43,00€2mg56,00€5mg93,00€10mg137,00€25mg231,00€50mg356,00€100mg530,00€500mg1.153,00€1mL*10mM (DMSO)92,00€Baricitinib phosphate
CAS :Baricitinib phosphate (INCB028050) is a selective orally bioavailable JAK1/JAK2 inhibitor.Formule :C16H20N7O6PSDegré de pureté :99.4% - 99.91%Couleur et forme :SolidMasse moléculaire :469.41Ref: TM-T2360
5mg40,00€10mg52,00€25mg73,00€50mg93,00€100mg105,00€200mg157,00€500mg260,00€1mL*10mM (DMSO)46,00€WHI-P97 HCl
WHI-P97 HCl is a potent and selective JAK-3 inhibitor.Formule :C16H14Br2ClN3O3Degré de pureté :99.49%Couleur et forme :SolidMasse moléculaire :491.56Ref: TM-T4657L
2mg34,00€5mg48,00€10mg86,00€25mg138,00€50mg182,00€100mg261,00€200mg371,00€1mL*10mM (DMSO)73,00€SJ000291942
CAS :SJ000291942 is an activator of the canonical bone morphogenetic proteins (BMP) signaling pathway.Formule :C16H15FN2O4Degré de pureté :99.66%Couleur et forme :SolidMasse moléculaire :318.3Ref: TM-T4662
1mg34,00€2mg44,00€5mg63,00€10mg100,00€25mg205,00€50mg349,00€100mg557,00€200mg790,00€1mL*10mM (DMSO)71,00€ZINC00881524
CAS :ZINC00881524 (ROCK inhibitor) is an effective and specific ROCK inhibitor.
Formule :C21H20N2O3SDegré de pureté :99.48%Couleur et forme :SolidMasse moléculaire :380.46Abrocitinib
CAS :Abrocitinib (PF-04965842) (PF-04965842) is a potent, specific and orally-active JAK1 inhibitor (IC50s: 29/803 nM for JAK1/2).Formule :C14H21N5O2SDegré de pureté :99.09% - 99.91%Couleur et forme :SolidMasse moléculaire :323.41LSKL, Inhibitor of Thrombospondin TSP-1 2TFA
LSKL, Inhibitor of Thrombospondin TSP-1 acetate is activation of TGF-β .Formule :C25H44F6N6O9Degré de pureté :99.75%Couleur et forme :SolidMasse moléculaire :686.64Ref: TM-T7676
2mg42,00€5mg54,00€10mg84,00€25mg138,00€50mg207,00€100mg316,00€200mg442,00€1mL*10mM (DMSO)93,00€SC99
CAS :SC99 inhibits JAK2-STAT3, reducing STAT3 genes, platelet activity, and has anti-myeloma, anti-thrombotic effects.Formule :C15H8Cl2FN3ODegré de pureté :99.56%Couleur et forme :SolidMasse moléculaire :336.15Ref: TM-T8719
1mg43,00€5mg87,00€10mg133,00€25mg227,00€50mg344,00€100mg429,00€200mg597,00€1mL*10mM (DMSO)94,00€Kartogenin
CAS :Kartogenin (KGN) is an activator of the smad4/smad5 pathway, and promotes the selective differentiation of multipotent mesenchymal stem cells into chondrocytes.Formule :C20H15NO3Degré de pureté :96.25% - 97.79%Couleur et forme :SolidMasse moléculaire :317.34TBB
CAS :TBB (NSC-231634)(NSC-231634) is a highly selective, ATP/GTP-competitive inhibitor of casein kinase-2 (CK2).
Formule :C6HBr4N3Degré de pureté :98.51% - 99.45%Couleur et forme :Off-White SolidMasse moléculaire :434.71ITD-1
CAS :ITD-1 is a potent and highly selective TGFβ pathway inhibitor.Formule :C27H29NO3Degré de pureté :99.89% - >99.99%Couleur et forme :SolidMasse moléculaire :415.52WP1066
CAS :WP1066 is a inhibitor of JAK2 (IC50: 2.30 μM) and STAT3 (IC50: 2.43 μM) in HEL cells; shows activity to JAK2, STAT3/5, and ERK1/2, not JAK1 and JAK3.Formule :C17H14BrN3ODegré de pureté :98.92% - 99.73%Couleur et forme :SolidMasse moléculaire :356.22Galunisertib
CAS :Galunisertib (LY2157299) is a selective TGF-β receptor type I (TGF-βRI) inhibitor. Galunisertib has antitumor activity. Cost-effective and quality-assured.Formule :C22H19N5ODegré de pureté :97.09% - 99.98%Couleur et forme :SolidMasse moléculaire :369.42Ref: TM-T2510
1g657,00€5mg46,00€10mg52,00€25mg84,00€50mg114,00€100mg178,00€200mg269,00€500mg442,00€1mL*10mM (DMSO)52,00€AZ960
CAS :AZ960 is an effective ATP competitive JAK2 inhibitor (IC50/Ki: <3 nM and0.45 nM).Formule :C18H16F2N6Degré de pureté :96.02% - 99.88%Couleur et forme :SolidMasse moléculaire :354.36WDR5-0103 hydrochloride[890190-22-4(free base)]
WDR5-0103 hydrochloride[890190-22-4(free base)] (WD-Repeat Protein 5-0103) is an effective and specific WD repeat-containing protein 5 (WDR5) antagonist (Kd:Formule :C21H26ClN3O4Degré de pureté :99.66%Couleur et forme :SolidMasse moléculaire :419.9SHR0302
CAS :SHR0302 (ARQ252) is a JAK inhibitor that binds JAK1 with stronger affinity than others (Selectivity for JAK1 is more than 10 times for JAK2, 77 times for JAK3,Formule :C18H22N8O2SDegré de pureté :99.11%Couleur et forme :SolidMasse moléculaire :414.48Ref: TM-T9195
1mg80,00€5mg183,00€10mg298,00€25mg512,00€50mg817,00€100mg1.311,00€1mL*10mM (DMSO)167,00€Itacitinib
CAS :Itacitinib (INCB039110) is an orally bioavailable inhibitor of Janus-associated kinase 1 (JAK1) with potential antineoplastic activity.Formule :C26H23F4N9ODegré de pureté :96.4% - 99.5%Couleur et forme :SolidMasse moléculaire :553.51Tofacitinib
CAS :Tofacitinib (Tasocitinib) is an orally Janus kinase inhibitor. Tofacitinib is used for the treatment of rheumatoid arthritis. Cost effective and quality assured.Formule :C16H20N6ODegré de pureté :99% - >99.99%Couleur et forme :SolidMasse moléculaire :312.37Ruxolitinib
CAS :Ruxolitinib (INCB018424) is a JAK1/2 inhibitor (IC50=3.3/2.8 nM) that is potent and selective.Formule :C17H18N6Degré de pureté :99.4% - >99.99%Couleur et forme :SolidMasse moléculaire :306.36Ref: TM-T1829
5mg55,00€10mg71,00€25mg96,00€50mg110,00€100mg146,00€200mg231,00€500mg393,00€1mL*10mM (DMSO)62,00€IWP L6
CAS :IWP L6 (Porcn Inhibitor III) is an extremely effective Porcn inhibitor (EC50: 0.5 nM).
Formule :C25H20N4O2S2Degré de pureté :99.51% - >99.99%Couleur et forme :SolidMasse moléculaire :472.58SD-208
CAS :SD-208 (ALK5 Inhibitor V), a selective TGF-βRI (ALK5) inhibitor (IC50: 48 nM), is >100-fold selectivity over TGF-βRII.Formule :C17H10ClFN6Degré de pureté :98.72% - 99.65%Couleur et forme :SolidMasse moléculaire :352.75TED-347
CAS :TED-347 is an irreversible and covalent inhibitor of TEAD4-Yap1 protein-protein interaction(EC50 of 5.9 μM), and inhibits glioblastoma cell viability.Formule :C15H11ClF3NODegré de pureté :99.9%Couleur et forme :SolidMasse moléculaire :313.7Solcitinib
CAS :Solcitinib (GLPG-0778), a JAK1 inhibitor, may treat psoriasis, ulcerative colitis, and lupus.
Formule :C22H23N5O2Degré de pureté :99.61% - 99.82%Couleur et forme :SolidMasse moléculaire :389.45Fosifidancitinib
CAS :Fosifidancitinib is a potent inhibitor of JAK 1 and JAK 3.Formule :C21H21FN5O7PDegré de pureté :99.54%Couleur et forme :SolidMasse moléculaire :505.39Ref: TM-T38624
1mg93,00€2mg117,00€5mg177,00€10mg269,00€25mg429,00€50mg610,00€100mg820,00€200mg1.099,00€PF-5274857
CAS :PF-5274857: selective hedgehog pathway inhibitor (IC50: 5.8 nM, Ki: 4.6 nM), treats brain tumors, crosses blood-brain barrier, orally stable.Formule :C20H25ClN4O3SDegré de pureté :98.53%Couleur et forme :SolidMasse moléculaire :436.96SRI-011381
CAS :SRI-011381, a new-type agonist of the TGF-beta signaling pathway, is utilized in the treatment of Alzheimer's disease.Formule :C20H31N3ODegré de pureté :98.64%Couleur et forme :SolidMasse moléculaire :329.48Oclacitinib maleate
CAS :Oclacitinib maleate is a selective JAK inhibitor (IC50: 10-99 nM; JAK1 cytokines: 36-249 nM), with no effect on 38 non-JAK kinases.Formule :C15H23N5O2S·C4H4O4Degré de pureté :99.17% - 99.92%Couleur et forme :SolidMasse moléculaire :453.51Ref: TM-T6914
1mg37,00€2mg52,00€5mg74,00€10mg94,00€25mg166,00€50mg258,00€100mg432,00€1mL*10mM (DMSO)81,00€GSK269962A
CAS :GSK269962A (GSK269962A HCl) is a selective ROCK(Rho-associated protein kinase) inhibitor with IC50 values of 1.6 and 4 nM for ROCK1 and ROCK2, respectively.Formule :C29H30N8O5Degré de pureté :99.14% - 99.71%Couleur et forme :SolidMasse moléculaire :570.6Oclacitinib
CAS :Oclacitinib (PF-03394197)(PF03394197) is a potent and selective JAKs inhibitor with IC50 of 10-99 nM; not inhibit a panel of 38 non-JAK kinases (IC50 's > 1000Formule :C15H23N5O2SDegré de pureté :98% - 98.45%Couleur et forme :White To Off-White SolidMasse moléculaire :337.44AZD-1480
CAS :AZD1480: JAK2 inhibitor, IC50 0.26 nM; selective vs Tyk2, JAK3; less on JAK1. Used in solid tumors, PPV, PMF, ET trials.Formule :C14H14ClFN8Degré de pureté :98.25% - 99.47%Couleur et forme :SolidMasse moléculaire :348.77JAK-IN-5 hydrochloride
CAS :JAK-IN-5 hydrochloride is a JAK inhibitor [1].Formule :C27H32ClFN6OCouleur et forme :SolidMasse moléculaire :511.03EasyStep Human Cys-C(CystatinC) ELISA Kit
The test principle applied in this kit is Sandwich enzyme immunoassay. The microtiter plate provided in this kit has been pre-coated with an antibody specific to Human Cys-C, and the Human Cys-C standard plate wells that pre-coated using protein-related techniques are provided separately. Standard/Sample Diluent Buffer or samples are added to the appropriate microtiter plate wells ,then added a HRP-conjugated antibody specific to Human Cys-C. After TMB substrate solution is added, only those wells that contain Human Cys-C and HRP-conjugated antibody will exhibit a change in color. The enzyme-substrate reaction is terminated by the addition of sulphuric acid solution and the color change is measured spectrophotometrically at a wavelength of 450nm ± 10nm. The concentration of Human Cys-C in the samples is then determined by comparing the OD of the samples to the standard curve.Couleur et forme :Colourless TransparentliquidCHIR 98024
CAS :CHIR 98024: strong GSK-3α/β blocker, IC50 0.65/0.58 nM, selective over Cdc2/ERK2.Formule :C20H17Cl2N9O2Degré de pureté :99.45%Couleur et forme :SolidMasse moléculaire :486.31Ref: TM-T3074
1mg44,00€2mg55,00€5mg96,00€10mg153,00€25mg298,00€50mg487,00€100mg705,00€1mL*10mM (DMSO)97,00€PRI-724
CAS :PRI-724 is a second-generation, selective small molecule inhibitor of the β-catenin/CBP interaction.Cost-effective and quality-assured.
Formule :C33H35N6O7PDegré de pureté :98.25% - 99.11%Couleur et forme :SoildMasse moléculaire :658.64VT107
CAS :VT107 is a potent pan-TEAD autopalmitoylation inhibitor. VT-107 can be used in cancer therapy research.Cost-effective and quality-assured.Formule :C25H20F3N3ODegré de pureté :99.72% - 99.92%Couleur et forme :SolidMasse moléculaire :435.44Ref: TM-T35545
1mg130,00€5mg314,00€10mg477,00€25mg768,00€50mg1.045,00€100mg1.406,00€200mg1.882,00€1mL*10mM (DMSO)343,00€Osunprotafib
CAS :Osunprotafib (ABBV-CLS-484) is a potent, orally bioavailable PTP1B/PTPN2 inhibitor in clinical trials for solid tumors.Cost-effective and quality-assured.Formule :C17H24FN3O4SDegré de pureté :97.11% - 99.91%Couleur et forme :SolidMasse moléculaire :385.45YAP/TAZ inhibitor-2
CAS :Potent oral TEAD-YAP/TAZ inhibitor-2 with 3 nM EC50; exhibits anti-proliferative and antitumor effects.Formule :C19H14F4N4ODegré de pureté :98.65%Couleur et forme :SoildMasse moléculaire :390.33Ref: TM-T60218
1mg87,00€2mg113,00€5mg177,00€10mg281,00€25mg475,00€50mg687,00€100mg964,00€500mg1.918,00€1mL*10mM (DMSO)197,00€Cerdulatinib hydrochloride
CAS :Cerdulatinib hydrochloride is an oral tyrosine kinase inhibitor targeting JAK1/2/3, TYK2, Syk, and 19 others with IC50 < 200 nM.Formule :C20H28ClN7O3SDegré de pureté :99.85%Couleur et forme :SolidMasse moléculaire :482RO7185876
CAS :RO7185876 is a selective gamma secretase modulator, which can be used in the study of Alzheimer's disease.Formule :C25H28F3N7Degré de pureté :99.50%Couleur et forme :SolidMasse moléculaire :483.532Sulindac EP Impurity C-d3
CAS :Sulindac EP Impurity C-d3 is a deuterated compound of Sulindac EP Impurity C. Sulindac EP Impurity C has a CAS number of 32004-67-4. (E/Z)-Sulindac sulfide is a potent γ-secretase modulator (GSM) that selectively reduces Aβ42 production in favor of shorter Aβ species. (E/Z)-Sulindac sulfide can be used for researching Alzheimer's disease [1].Formule :C20H14D3FO2SCouleur et forme :SolidMasse moléculaire :343.43NVP-BSK805
CAS :NVP-BSK805 (BSK 805) is an ATP-competitive JAK2 inhibitor.Formule :C27H28F2N6ODegré de pureté :98%Couleur et forme :SolidMasse moléculaire :490.55Livmoniplimab
CAS :Livmoniplimab (ABBV-151; ARGX-115) is a humanised monoclonal antibody targeting LRRC32 (GARP)/TGFβ1, which blocks TGFβ1 release mediated by LRRC32Degré de pureté :95%Couleur et forme :LiquidMasse moléculaire :~150 kDaNisevokitug
CAS :Nisevokitug (anti-TGF-β mAb) neutralizes TGF-β and is being studied for its ability to modulate the immunosuppressive tumor microenvironment.Degré de pureté :95%Couleur et forme :LiquidMasse moléculaire :143.51 kDaTrevogrumab
CAS :Trevogrumab is a human monoclonal antibody that inhibits myostatin (GDF8) to promote muscle growth, and is under research for treating age-related muscle loss (sarcopenia).Degré de pureté :95% - 97.6% (SDS-PAGE); 95.9% (SEC-HPLC)Couleur et forme :LiquidMasse moléculaire :144.02 kDaDilpacimab
CAS :Dilpacimab (ABT165) is a dual-variable antibody that targets DLL4 and VEGF pathways, showing potential in cancer research by blocking angiogenesis and Notch.Degré de pureté :95% - 97.7% (SDS-PAGE); 95.6% (SEC-HPLC)Couleur et forme :LiquidMetelimumab
CAS :Metelimumab (CAT-192) is a humanised monoclonal antibody targeting TGFβ1, which can be used to study diffuse systemic sclerosis (d-SSc).Degré de pureté :95%Couleur et forme :LiquidMasse moléculaire :~150 kDaTarextumab
CAS :Tarextumab is an anti-Notch2/3 mAb, a promising candidate for breast, lung, ovarian, and pancreatic cancers.Degré de pureté :95%Couleur et forme :LiquidMasse moléculaire :~150 kDaGinisortamab
CAS :Ginisortamab (UCB6114) is a fully humanized monoclonal antibody targeting Gremlin-1, IC50=8.2 nM and 9 nM against human and mouse Gremlin-1, respectively.Degré de pureté :95% - 96.0% (SDS-PAGE); 97.0% (SEC-HPLC)Couleur et forme :LiquidMasse moléculaire :147.55 kDa(3S,4S)-Tofacitinib
CAS :(3S,4S)-Tofacitinib, a less active enantiomer of tofacitinib, is a Janus kinases inhibitor.Formule :C16H20N6ODegré de pureté :98%Couleur et forme :SolidMasse moléculaire :312.37TEAD-IN-2
CAS :TEAD-IN-2 is a potent and bifunctional TEAD inhibitor to induce TEAD protein degradation via the ubiquitination pathway, with anticancer potential.Formule :C16H18BrF3N2OCouleur et forme :SolidMasse moléculaire :391.23RR-11a
CAS :RR-11a is a synthetic enzyme Legumain inhibitor.
Formule :C24H28N6O10Degré de pureté :98%Couleur et forme :SolidMasse moléculaire :560.51ELN318463 racemate
CAS :ELN318463 racemate (ELN 318463 racemate) is the racemate of ELN318463 which is an amyloid precursor protein (APP) selective γ-secretase inhibitor.Formule :C19H20BrClN2O3SDegré de pureté :99.69%Couleur et forme :SolidMasse moléculaire :471.8Ref: TM-T11178L
1mg154,00€5mg370,00€10mg583,00€25mg858,00€50mg1.170,00€100mg1.575,00€1mL*10mM (DMSO)424,00€JAK3-IN-9
CAS :JAK3-IN-9, potent JAK3 inhibitor, IC50 of 1.7 nM, highly selective, low toxicity, orally bioavailable, shows anti-arthritis activity.Formule :C17H23N5O4SCouleur et forme :SolidMasse moléculaire :393.46INCB16562
CAS :INCB16562: oral JAK1/2 inhibitor, halts IL-6/STAT3 in myeloma cells, boosts drug efficacy, stunts myeloma in mice.Formule :C19H11Cl2N5Couleur et forme :SolidMasse moléculaire :380.23γ-secretase modulator 1
CAS :gamma-secretase modulator 1 is a modulator of γ secretase and can be used in studies about the treatment of Alzheimer's disease.Formule :C24H24N4OSDegré de pureté :99.75% - 99.96%Couleur et forme :SolidMasse moléculaire :416.54TK4b
CAS :TK4b, a JAK inhibitor, targets leukemia/lymphoid diseases, with IC50s: 18.42 nM (JAK3) & 19.40 nM (JAK2).Formule :C21H22N2O2Couleur et forme :SolidMasse moléculaire :334.41TUL01101
CAS :TUL01101, a selective oral JAK1 inhibitor (IC50: 3 nM), also targets JAK2, JAK3, TYK2; for rheumatoid arthritis research.Formule :C22H25F2N5O2Couleur et forme :SolidMasse moléculaire :429.46JAK3-IN-1
CAS :JAK3-IN-1 is an orally active, selective and potent JAK3 inhibitor for the study of immune system disorders.Formule :C26H30ClN7O2Couleur et forme :SolidMasse moléculaire :508.02JI051
CAS :JI051 has anti-tumor effects and can interact with PHB2 to inhibit the proliferation of HEK293 cells and pancreatic cancer cells.Formule :C22H24N2O3Degré de pureté :≥98% - ≥98.0%Couleur et forme :SolidMasse moléculaire :364.44γ-Secretase modulator 11
CAS :5-{8-[(3,4'-Difluoro[1,1'-biphenyl]-4-yl)methoxy]-2-methylimidazo[1,2-a]pyridin-3-yl}-N-methylpyridine-2-carboxamide (1o) exhibited high in vitro potency andFormule :C28H22F2N4O2Couleur et forme :SolidMasse moléculaire :484.5JA310
CAS :JA310 is a highly selective inhibitor of the MST3 kinase, demonstrating significant cellular potency with an EC50 value of 106 nM [1].Formule :C17H19N7OCouleur et forme :SolidMasse moléculaire :337.38CP-690550A
CAS :Cp-690550a is a novel JAK3 inhibitor, which is used to treat rheumatoid arthritis, graft rejection, psoriasis, and other immune-mediated diseases.Formule :C15H21N5O2Couleur et forme :SolidMasse moléculaire :303.36AC430
CAS :AC430, a specific JAK2 inhibitor for cancer and autoimmune therapy, excels in preclinical trials with low doses. Developed by Ambit.Formule :C19H16FN5OCouleur et forme :SolidMasse moléculaire :349.36SYK/JAK-IN-1
CAS :SYK/JAK-IN-1 is a dual SYK/JAK inhibitor with IC50 values of less than 5 nM for both SYK and JAK2.Formule :C24H26N8O3Couleur et forme :SolidMasse moléculaire :474.52GDC-4379
CAS :GDC-4379 is a JAK1 inhibitor that can be used to study asthma.Formule :C21H18ClF2N7O3Couleur et forme :SolidMasse moléculaire :489.86PF-00956980
CAS :PF-00956980: reversible JAK inhibitor, IC50: JAK1 (2.2μM), JAK2 (23.1μM), JAK3 (59.9μM), for lung/skin inflammation research.Formule :C18H26N6OCouleur et forme :SolidMasse moléculaire :342.441,2,3,4,5,6-Hexabromocyclohexane
CAS :Inhibits JAK2 autophosphorylation; non-cytotoxic at 100μM; 1μM reduces activity by 50%, 50μM nearly abolishes it.Formule :C6H6Br6Degré de pureté :98%Couleur et forme :SolidMasse moléculaire :557.54Peficitinib hydrobromide
CAS :Peficitinib hydrobromide is used in the treatment of Psoriasis and Rheumatoid Arthritis.Formule :C18H23BrN4O2Couleur et forme :SolidMasse moléculaire :407.312
![WDR5-0103 hydrochloride[890190-22-4(free base)]](/_next/image/?url=https%3A%2Fstatic.cymitquimica.com%2Fproducts%2FTM%2Fthumb-webp%2FT5140.webp&w=3840&q=75)
